Literature DB >> 16406160

Assembly of bacteriophage Qbeta virus-like particles in yeast Saccharomyces cerevisiae and Pichia pastoris.

Janis Freivalds1, Andris Dislers, Velta Ose, Dace Skrastina, Indulis Cielens, Paul Pumpens, Kestutis Sasnauskas, Andris Kazaks.   

Abstract

Recombinant bacteriophage Qbeta coat protein (CP), which has been proposed as a promising carrier of foreign epitopes via their incorporation either by gene engineering techniques or by chemical coupling, efficiently self-assembles into virus-like particles (VLPs) when expressed in Escherichia coli. Here, we demonstrate expression and self-assembly of Qbeta CP in yeast Saccharomyces cerevisiae and Pichia pastoris. Production reached 3-4 mg/1g of wet cells for S. cerevisiae and 4-6 mg for P. pastoris, which was about 15-20% and 20-30% of the E. coli expression level, respectively. Qbeta VLPs were easily purified by size-exclusion chromatography in both cases and contained nucleic acid, shown by native agarose gel electrophoresis. The obtained particles were highly immunogenic in mice and the resulting sera recognized both E. coli- and yeast-derived Qbeta VLPs equally well.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16406160     DOI: 10.1016/j.jbiotec.2005.11.013

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  11 in total

1.  Internal core protein cleavage leaves the hepatitis B virus capsid intact and enhances its capacity for surface display of heterologous whole chain proteins.

Authors:  Andreas Walker; Claudia Skamel; Jolanta Vorreiter; Michael Nassal
Journal:  J Biol Chem       Date:  2008-09-30       Impact factor: 5.157

Review 2.  Design of virus-based nanomaterials for medicine, biotechnology, and energy.

Authors:  Amy M Wen; Nicole F Steinmetz
Journal:  Chem Soc Rev       Date:  2016-07-25       Impact factor: 54.564

3.  Yeast-expressed bacteriophage-like particles for the packaging of nanomaterials.

Authors:  Janis Freivalds; Svetlana Kotelovica; Tatyana Voronkova; Velta Ose; Kaspars Tars; Andris Kazaks
Journal:  Mol Biotechnol       Date:  2014-02       Impact factor: 2.695

4.  Engineered mutations change the structure and stability of a virus-like particle.

Authors:  Jason D Fiedler; Cody Higginson; Marisa L Hovlid; Alexander A Kislukhin; Alexandra Castillejos; Florian Manzenrieder; Melody G Campbell; Neil R Voss; Clinton S Potter; Bridget Carragher; M G Finn
Journal:  Biomacromolecules       Date:  2012-07-25       Impact factor: 6.988

5.  Unnatural amino acid incorporation into virus-like particles.

Authors:  Erica Strable; Duane E Prasuhn; Andrew K Udit; Steven Brown; A James Link; John T Ngo; Gabriel Lander; Joel Quispe; Clinton S Potter; Bridget Carragher; David A Tirrell; M G Finn
Journal:  Bioconjug Chem       Date:  2008-03-05       Impact factor: 4.774

6.  Escherichia coli-derived virus-like particles in vaccine development.

Authors:  Xiaofen Huang; Xin Wang; Jun Zhang; Ningshao Xia; Qinjian Zhao
Journal:  NPJ Vaccines       Date:  2017-02-09       Impact factor: 7.344

Review 7.  Bioengineering Strategies for Protein-Based Nanoparticles.

Authors:  Dennis Diaz; Andrew Care; Anwar Sunna
Journal:  Genes (Basel)       Date:  2018-07-23       Impact factor: 4.096

8.  Self-Assembly of Tail Tube Protein of Bacteriophage vB_EcoS_NBD2 into Extremely Long Polytubes in E. coli and S. cerevisiae.

Authors:  Aliona Špakova; Eugenijus Šimoliūnas; Raminta Batiuškaitė; Simonas Pajeda; Rolandas Meškys; Rasa Petraitytė-Burneikienė
Journal:  Viruses       Date:  2019-03-01       Impact factor: 5.048

Review 9.  Different applications of virus-like particles in biology and medicine: Vaccination and delivery systems.

Authors:  Zeinab Shirbaghaee; Azam Bolhassani
Journal:  Biopolymers       Date:  2016-03       Impact factor: 2.505

Review 10.  Construction and characterization of virus-like particles: a review.

Authors:  Andris Zeltins
Journal:  Mol Biotechnol       Date:  2013-01       Impact factor: 2.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.